2025-522475-28-00
CTIS ↗
TNX-103-07
Pulmonary Hypertension (PH) with Heart Failure with preserved left ventricular ejection fraction (PH-HFpEF)
pharma · Coronary Artery Bypass Grafting · Hypertension Pulmonary Secondary · TENX
TENAX THERAPEUTICS
TENAX THERAPEUTICS, INC.
TENAX THERAPEUTICS trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Chapel Hill, USA HQ
19 Employees
Public company Type
TENX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Chapel Hill, USA
- Employees
- 19
- Programs
- 7
- Drugs
- 2
- Patents
- 4
TENAX THERAPEUTICS clinical trials
Registry index of 9 ClinicalTrials.gov studies linked to TENAX THERAPEUTICS programs — each row shows trial ID, program name, phase, status, and indication.
TENAX THERAPEUTICS trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for TENAX THERAPEUTICS.